Why Do Biotechs Love the IRS Today? Washington Companies Just Got $34M in Grants

IsoRay Medical $526,510

Kineta $733,435

Koronis Pharmaceuticals $244,479

Kurve Technology $244,479

Light Sciences Oncology $488,958

Marina Biotech $244,479

MediQuest Therapeutics $244,479

Micronics $244,479

Mirabilis Medica $244,479

Mirina $488,958

Nanoquantum Sciences $244,479

NanoString Technologies $244,479

Northwest Biotherapeutics $244,479

Nortis $28,823

Oasis Diagnostics $14,367

Omeros $1,585,803

OncoGenex Pharmaceuticals $488,958

Onconome $231,016

Oncothyreon $485,958

Ondine Research Laboratories $244,479

Onkor Pharmaceuticals $488,958

Pacific Biomarkers $244,479

Pathway Medical Technologies $244,479

Author: Luke Timmerman

Luke is an award-winning journalist specializing in life sciences. He has served as national biotechnology editor for Xconomy and national biotechnology reporter for Bloomberg News. Luke got started covering life sciences at The Seattle Times, where he was the lead reporter on an investigation of doctors who leaked confidential information about clinical trials to investors. The story won the Scripps Howard National Journalism Award and several other national prizes. Luke holds a bachelor’s degree in journalism from the University of Wisconsin-Madison, and during the 2005-2006 academic year, he was a Knight Science Journalism Fellow at MIT.